Track Trident Lifeline Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -2.84 %
Low
381.0
High
425.0
1 Month returns: 1.96 %
Low
355.0
High
425.0
1 Year returns: 34.43 %
Low
229.9
High
425.0
3 Year CAGR: 30.98 %
Low
136.0
High
425.0
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Trident Lifeline Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Trident Lifeline Ltd. Shareholding Pattern
Quarterly breakdown of Trident Lifeline Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Trident Lifeline Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Trident Lifeline Ltd.?
The current share price of Trident Lifeline Ltd. is ₹ 410.00 as of 23 Oct 2026.
What is the market capitalisation of Trident Lifeline Ltd.?
The market capitalisation of Trident Lifeline Ltd. stands at ₹ 491.22 Cr.
What is the PE ratio of Trident Lifeline Ltd.?
The Price-to-Earnings (PE) ratio of Trident Lifeline Ltd. is 19.41 as of the latest trailing twelve months data.
What is the ROE and ROCE of Trident Lifeline Ltd.?
Trident Lifeline Ltd. has a Return on Equity (ROE) of 23.10% and a Return on Capital Employed (ROCE) of 14.47% as per the latest financial reports.
What is the 52-week high and low of Trident Lifeline Ltd.?
The 52-week high of Trident Lifeline Ltd. is - and the 52-week low is -.
What is the dividend yield of Trident Lifeline Ltd.?
The dividend yield of Trident Lifeline Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Trident Lifeline Ltd.?
Foreign Institutional Investors (FII) hold 1.16%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 30.16% of Trident Lifeline Ltd. shares.
What sector does Trident Lifeline Ltd. belong to?
Trident Lifeline Ltd. operates in the Healthcare sector.
What is the beta of Trident Lifeline Ltd.?
The beta of Trident Lifeline Ltd. is 0.04, indicating its price volatility relative to the broader market. Over the past 1 year, Trident Lifeline Ltd. has delivered an absolute return of 40.53%.
What is the RSI of Trident Lifeline Ltd.?
The 14-day Relative Strength Index (RSI) of Trident Lifeline Ltd. is 61.12, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Trident Lifeline Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
PE TTM of 19.41 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -36.3%
What is P/E Ratio?
Median: 30.47
Value 19.41
-0.82614.73
Strong price momentum
Price Momentum score of 97.4 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term
What is Price Momentum score?
97.4 / 100
Negative
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Company's earnings are of moderate quality
Earnings quality score of 31.7 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
31.7 / 100
No red flags found!
No significant red flags found in the stock.
410.0015.8 (3.99%)
36.67% in past 1 year
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Promoter
69.57
69.85
69.99
70.04
70.04
70.04
67.48
65.51
62.99
62.99
63.04
63.04
63.11
64.11
62.85
62.59
62.46
Indian Promoter
69.57
68.80
68.94
68.99
68.99
68.99
66.43
64.45
61.94
61.94
61.99
61.99
62.06
63.10
62.31
62.04
61.92
Foreign Promoter
-
1.05
1.05
1.05
1.05
1.05
1.05
1.05
1.05
1.05
1.05
1.05
1.04
1.01
0.55
0.55
0.55
Institutions
2.94
4.20
4.39
4.36
4.64
4.64
6.02
6.02
6.09
6.09
6.71
7.60
8.12
7.39
7.51
5.51
1.37
Mutual Funds / UTI
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
2.94
4.20
4.39
4.36
4.64
4.64
6.02
6.02
6.09
6.09
6.62
7.21
7.71
7.04
7.24
5.25
1.16
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.09
0.39
0.41
0.35
0.27
0.26
0.21
Non-Institution
27.49
25.95
25.62
25.60
25.32
25.32
26.50
28.47
30.92
30.92
30.25
29.36
28.78
28.50
29.64
31.90
36.17
Bodies Corporate
3.87
8.48
8.94
9.13
8.84
9.16
7.30
7.34
8.21
8.36
8.55
7.93
6.58
6.20
5.48
5.47
6.01
Others (incl. Retail)
No. of shareholders
23.62
1,373
17.47
380
16.68
369
16.47
367
16.48
414
16.16
455
19.20
480
21.13
479
22.71
480
22.56
492
21.70
502
21.43
519
22.20
526
22.30
549
24.16
579
26.43
680
30.16
1,015
Name
Month
Transaction
Holding % pre transaction
Average price
Qty.
Transaction value
HARDIK DESAI FAMILY TRUST
Promoter Group
June-2026
Market Purchase (Buy)
1st Jun 2026
7.07 %
₹ 248.82
9.00 k
₹ 22.39 lac
AMIT BHUPENDRABHAI HALVAWALA
Promoter Group
April-2026
Market Sale (Disposal)
1st Apr 2026
1.14 %
₹ 257.76
34.80 k
₹ 89.70 lac
RINKAL MAYURBHAI GAJERA
Promoter
April-2026
Market Sale (Disposal)
1st Apr 2026
3.98 %
₹ 262.24
76.20 k
₹ 2.00 cr
HARDIK DESAI FAMILY TRUST
Promoter Group
March-2026
Market Purchase (Acquisition)
31st Mar 2026
7.06 %
₹ 254.98
1.20 k
₹ 3.06 lac
Rupaben Chetan Jariwala
Promoter
March-2026
Market Sale (Disposal)
31st Mar 2026
5.53 %
₹ 248.12
39.60 k
₹ 98.26 lac
HARDIK DESAI FAMILY TRUST
Promoter Group
March-2026
Market Purchase (Acquisition)
16th Mar 2026
7.03 %
₹ 247.00
4.20 k
₹ 10.37 lac
HARDIK DESAI FAMILY TRUST
Promoter Group
February-2026
Market Purchase (Acquisition)
23rd Feb 2026
6.98 %
₹ 260.28
1.20 k
₹ 3.12 lac
Rupaben Chetan Jariwala
Promoter
February-2026
Market Sale (Disposal)
23rd Feb 2026
5.78 %
₹ 266.84
27.00 k
₹ 72.05 lac
Rupaben Chetan Jariwala
Promoter
February-2026
Market Sale (Disposal)
16th Feb 2026
5.81 %
₹ 273.06
3.60 k
₹ 9.83 lac
Rupaben Chetan Jariwala
Promoter
February-2026
Market Sale (Disposal)
16th Feb 2026
5.89 %
₹ 279.00
9.60 k
₹ 26.78 lac
Company Profile
Overview of Trident Lifeline Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Trident Lifeline Limited (TLL) is an India-based medication provider. The Company produces and sells finished doses. Its geographical segment includes India, Ghana, Kenya, Peru, Cameroon, Venezuela, and the Rest of the World. It discovered manufacturing formulations under its own brands alongside a loan license and a contract manufacturing model. It deals in capsules, tablets, liquid ointments, gels, ice gels, mouthwash, paste, solution, suspension, toothpaste, syrup, and cream. The product portfolio of the Company comprises a wide range of drugs like Anti-Bacterial, Anti-Diarrheal, Anti-Fungal, Anti-Malarial, Anti-Diabetic, Dental Cure, Pr, Multivitamin, Multimineral Nyteraceutoton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Anti-Lipidemic Drug, Anti-Parasiticical and Non-steroidal anti-inflammatory drugs (NSAIDS).
Trident Lifeline Limited (TLL) is an India-based medication provider. The Company produces and sells finished doses. Its geographical segment includes India, Ghana, Kenya, Peru, Cameroon, Venezuela, and the Rest of the World. It discovered manufacturing formulations under its own brands alongside a ...
Key personnel
Mrs. Nikita Sharma
Compliance Officer, Company Secretary
Mr. Shravan Harikrishna Patel
Managing Director
Mr. Hardik Jigishkumar DesaiD
Executive Chairman of the Board
Mr. Ashish Anandsingh BafnaD
Chief Financial Officer, Additional Executive Director
Mrs. Rupaben Chetanbhai JariwalaD
Whole-Time Director
Mr. Sachin BhandariD
Additional Non-Executive Independent Director
Ms. Smita Kiran DavdaD
Additional Non-Executive Independent Director
Mrs. Falguni Bhavesh JariwalaD
Additional Non-Executive Independent Women Director